Cargando…
Return on Investment of Free Colorectal Cancer Screening Tests in a Primarily Rural Uninsured or Underinsured Population in Northeast Texas
BACKGROUND: Colorectal cancer (CRC) is the third most common cancer in the USA. Its economic impact is extensive, and preventive screening services are warranted to help prevent it. OBJECTIVE: We sought to examine the return on investment, in terms of reduced costs attributed to cancer prevention, o...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7018884/ https://www.ncbi.nlm.nih.gov/pubmed/31123931 http://dx.doi.org/10.1007/s41669-019-0147-y |
_version_ | 1783497412258562048 |
---|---|
author | Orsak, Gabriela Miller, Anastasia Allen, Carlton M. Singh, Karan P. McGaha, Paul |
author_facet | Orsak, Gabriela Miller, Anastasia Allen, Carlton M. Singh, Karan P. McGaha, Paul |
author_sort | Orsak, Gabriela |
collection | PubMed |
description | BACKGROUND: Colorectal cancer (CRC) is the third most common cancer in the USA. Its economic impact is extensive, and preventive screening services are warranted to help prevent it. OBJECTIVE: We sought to examine the return on investment, in terms of reduced costs attributed to cancer prevention, of a CRC screening outreach program providing education and screening in a primarily rural region targeting the uninsured and underinsured. METHODS: The expenditures of the Northeast Texas CRC screening program were calculated for the years of 2016 and 2017. Prices ($US) were adjusted for inflation and converted to year 2017 values. The costs saved were calculated using the estimated costs of CRC care present in the literature. RESULTS: For fiscal years 2016 and 2017, the program provided an average return of $US1.46–2.06 for every tax dollar spent. Estimated cost avoidance was $US165,080 per avoided case and estimated cost avoidance of $US245,601 among early-stage cancer cases detected, resulting in potential savings ranging from $US3,893,676 to $US4,837,923. CONCLUSION: A CRC outreach program providing education and screening operating in less densely populated regions yields a positive return on investment. |
format | Online Article Text |
id | pubmed-7018884 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-70188842020-02-28 Return on Investment of Free Colorectal Cancer Screening Tests in a Primarily Rural Uninsured or Underinsured Population in Northeast Texas Orsak, Gabriela Miller, Anastasia Allen, Carlton M. Singh, Karan P. McGaha, Paul Pharmacoecon Open Original Research Article BACKGROUND: Colorectal cancer (CRC) is the third most common cancer in the USA. Its economic impact is extensive, and preventive screening services are warranted to help prevent it. OBJECTIVE: We sought to examine the return on investment, in terms of reduced costs attributed to cancer prevention, of a CRC screening outreach program providing education and screening in a primarily rural region targeting the uninsured and underinsured. METHODS: The expenditures of the Northeast Texas CRC screening program were calculated for the years of 2016 and 2017. Prices ($US) were adjusted for inflation and converted to year 2017 values. The costs saved were calculated using the estimated costs of CRC care present in the literature. RESULTS: For fiscal years 2016 and 2017, the program provided an average return of $US1.46–2.06 for every tax dollar spent. Estimated cost avoidance was $US165,080 per avoided case and estimated cost avoidance of $US245,601 among early-stage cancer cases detected, resulting in potential savings ranging from $US3,893,676 to $US4,837,923. CONCLUSION: A CRC outreach program providing education and screening operating in less densely populated regions yields a positive return on investment. Springer International Publishing 2019-05-23 /pmc/articles/PMC7018884/ /pubmed/31123931 http://dx.doi.org/10.1007/s41669-019-0147-y Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Original Research Article Orsak, Gabriela Miller, Anastasia Allen, Carlton M. Singh, Karan P. McGaha, Paul Return on Investment of Free Colorectal Cancer Screening Tests in a Primarily Rural Uninsured or Underinsured Population in Northeast Texas |
title | Return on Investment of Free Colorectal Cancer Screening Tests in a Primarily Rural Uninsured or Underinsured Population in Northeast Texas |
title_full | Return on Investment of Free Colorectal Cancer Screening Tests in a Primarily Rural Uninsured or Underinsured Population in Northeast Texas |
title_fullStr | Return on Investment of Free Colorectal Cancer Screening Tests in a Primarily Rural Uninsured or Underinsured Population in Northeast Texas |
title_full_unstemmed | Return on Investment of Free Colorectal Cancer Screening Tests in a Primarily Rural Uninsured or Underinsured Population in Northeast Texas |
title_short | Return on Investment of Free Colorectal Cancer Screening Tests in a Primarily Rural Uninsured or Underinsured Population in Northeast Texas |
title_sort | return on investment of free colorectal cancer screening tests in a primarily rural uninsured or underinsured population in northeast texas |
topic | Original Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7018884/ https://www.ncbi.nlm.nih.gov/pubmed/31123931 http://dx.doi.org/10.1007/s41669-019-0147-y |
work_keys_str_mv | AT orsakgabriela returnoninvestmentoffreecolorectalcancerscreeningtestsinaprimarilyruraluninsuredorunderinsuredpopulationinnortheasttexas AT milleranastasia returnoninvestmentoffreecolorectalcancerscreeningtestsinaprimarilyruraluninsuredorunderinsuredpopulationinnortheasttexas AT allencarltonm returnoninvestmentoffreecolorectalcancerscreeningtestsinaprimarilyruraluninsuredorunderinsuredpopulationinnortheasttexas AT singhkaranp returnoninvestmentoffreecolorectalcancerscreeningtestsinaprimarilyruraluninsuredorunderinsuredpopulationinnortheasttexas AT mcgahapaul returnoninvestmentoffreecolorectalcancerscreeningtestsinaprimarilyruraluninsuredorunderinsuredpopulationinnortheasttexas |